A scary result on a prenatal scan
Imagine going in for a routine pregnancy ultrasound.
The technician gets quiet. The doctor points to the back of the baby's neck and says the soft tissue looks thicker than expected. More tests follow. Then genetic testing shows a small piece of chromosome 17 is missing.
That is how many families first meet 17q22 deletion syndrome — a rare condition where a tiny stretch of one chromosome is gone.
17q22 deletion syndrome is uncommon. Until now, almost every reported case was found after birth, not before.
Children with the deletion often have intellectual disability, vision problems, and other brain and nerve differences. But the missing piece isn't the same size in every child, which made it hard to know which gene was actually causing the trouble.
Parents given a prenatal result often ask the same question: what does this mean for my baby? Without a clear answer, counseling has been very hard.
Zooming in on one gene
The old view was that the whole 17q22 region, as a block, caused the symptoms. That made counseling vague.
But here's the twist. In this case, careful sequencing pointed to one specific gene: SRSF1 (a gene that helps cells read their RNA correctly).
SRSF1 helps cells turn their DNA instructions into working proteins. It's part of the cell's editing team. When only one working copy is present instead of the normal two — called haploinsufficiency — brain cells appear to feel the shortage the most.
How it works, in plain terms
Think of SRSF1 as an editor at a newspaper.
Your DNA sends in rough drafts (RNA). The editor trims and arranges them into clean stories (proteins) that cells can actually use.
Lose one of your two editors, and the newsroom falls behind. Some stories come out garbled. The brain, which needs huge numbers of precise proteins to wire itself during pregnancy, is hit hardest.
This is not a condition parents caused.
In this fetus, the deletion was de novo — a brand-new change that happened at conception. Neither parent carried it.
The team studied one pregnancy. An ultrasound showed unusual features, including thickened nuchal tissue at the back of the neck.
Doctors ran three tests: karyotype (a picture of the chromosomes), chromosomal microarray (a higher-resolution scan for missing or extra pieces), and whole-exome sequencing (a readout of almost every gene).
They then searched the medical literature and found 24 earlier cases with overlapping 17q22 deletions. They compared features across all of them.
The deletion in this fetus covered a defined stretch of 17q22, and SRSF1 sat inside it.
Across the 24 older cases, every child with a deletion covering SRSF1 had similar neurological issues. That pattern strongly suggests SRSF1 is the key gene for the brain symptoms, not just a neighbor caught in the missing piece.
The fetus also had multiple structural differences visible on ultrasound, including distinctive facial features. The authors argue that prenatal ultrasound plus targeted genetic testing can now catch this pattern earlier than before.
Why this is different this time
For years, families received a 17q22 deletion result with a long list of "it might cause" possibilities.
Pinpointing SRSF1 narrows that list. It gives genetic counselors a real anchor. It also opens the door for future research on how to support children with this specific gene shortage.
This kind of gene-by-gene mapping is how rare chromosomal syndromes move from mystery to management. It happened with 22q11 deletion (DiGeorge syndrome) years ago.
Once the "driver" gene is known, researchers can study its biology in cells and animal models. Families gain a clearer diagnosis. Clinicians can watch for the specific problems that tend to show up.
If your prenatal testing has shown a 17q22 deletion, ask whether SRSF1 is inside the missing segment. That detail matters.
A genetic counselor can walk through what the latest evidence suggests for development, learning, vision, and long-term care. You do not have to figure this out alone.
If your child has already been diagnosed after birth, the same conversation is worth having. Early support — speech therapy, vision care, developmental services — often helps children with neurodevelopmental differences reach their strongest potential.
This report is based on one fetus and a review of 24 published cases. That is a small foundation.
Published cases also tend to describe the most noticeable features, which can skew the picture. We don't yet know the full range of outcomes for children with SRSF1-containing deletions.
Researchers will now study SRSF1 more deeply in lab models to understand exactly how its shortage changes brain development. Larger family registries will help map the real-world range of outcomes.
For families today, the most useful next step is working with a genetics team who can interpret your specific deletion, not just the syndrome name.
